Bharat Biotech inked a buy concurrence with the Government of India on January 11 to give 55 lakh portions of COVID-19 immunization Covaxin at Rs 295 for each portion, CNBC-TV18 announced.
The Indian pharma firm will give its Covid immunization straightforwardly to 12 states, and the cycle will be finished in two days by January 14. Dispatches will start from Hyderabad beginning January 12, the report said.
Bharat Biotech will give 38.5 lakh portions of the COVID-19 immunization in stage 1 and 16.5 dosages in stage 2.
#CNBCTV18Exclusive | Sources say Govt inks purchase agreement with Bharat Biotech for 55 lakh doses; Rs 295 per dose— CNBC-TV18 (@CNBCTV18Live) January 11, 2021
Govt asks Bharat Biotech to supply 55 lakh doses at 12 centres before Jan 14; Dispatches to begin from Hyderabad early tomorrow morning pic.twitter.com/YgEq3RGPlJ
Each single-portion vial will cost around Rs 295 or more duties, which implies each shot of Covaxin will cost around Rs 310.
Oxford-AstraZeneca's COVID-19 immunization Covishield, which is being fabricated by SII in India, will be accessible for Rs 220 for each vial (comprehensive of 14 percent GST) in India. The Center has inked an arrangement to obtain 11 million portions of the SII COVID-19 antibody for the huge Covid immunization rollout that is set to start from January 16.
Read More- Corona Virus Live Update